154 related articles for article (PubMed ID: 18814941)
1. [Monoclonal gammopathy and primary colonic mantle cell lymphoma].
Mohamed G; Kochlef A; Gargouri D; Kilani A; Elloumi H; Ouakaa A; Belhadj N; Romani M; Kharrat J; Ghorbel A
Rev Med Interne; 2009 Mar; 30(3):279-81. PubMed ID: 18814941
[TBL] [Abstract][Full Text] [Related]
2. [No Hodgkin lymphoma that mistakes with a colonic neoplasm].
Rodríguez Framil M; Martínez Rey C; González S; Alende Sixto R
An Med Interna; 2007 Apr; 24(4):203-4. PubMed ID: 17879482
[No Abstract] [Full Text] [Related]
3. Gastric and colonic mantle cell lymphoma - incidental discovery.
Pitigoi D; Stoica V; Stoia R; Dobrea C; Becheanu G; Diculescu M
J Gastrointestin Liver Dis; 2009 Mar; 18(1):85-8. PubMed ID: 19337640
[TBL] [Abstract][Full Text] [Related]
4. [Antibody therapy in hematology and oncology - part 1].
Kneba M; Schrader C; Köhne H
Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
[No Abstract] [Full Text] [Related]
5. Nonpolypoid intestinal mantle cell lymphoma resembling MALT lymphoma with successful response to rituximab.
D'Antonio A; Boscaino A; Addesso M; Liguori G; Nappi O
South Med J; 2008 Nov; 101(11):1168-9. PubMed ID: 19088534
[TBL] [Abstract][Full Text] [Related]
6. Phase 3 study of frontline rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in transplantation-unsuitable mantle cell lymphoma (MCL) patients.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):9-11. PubMed ID: 25768994
[No Abstract] [Full Text] [Related]
7. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S
J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
[TBL] [Abstract][Full Text] [Related]
8. [A 63-old patient with right-sided hypogastric pain at 6 months after appendectomy].
Handschin D; Zeller A; Wiesner W; Buess M
Praxis (Bern 1994); 2004 Jan; 93(1-2):24-6. PubMed ID: 14964041
[No Abstract] [Full Text] [Related]
9. Wells' syndrome with a clinicopathological correlation associated with mantle-cell lymphoma.
Pessach I; Petevi K; Gkirkas K; Stamouli M; Constantinou P; Rontogianni D; Dimitriadis G; Tsirigotis P
Leuk Lymphoma; 2016 Nov; 57(11):2702-4. PubMed ID: 26999270
[No Abstract] [Full Text] [Related]
10. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
[No Abstract] [Full Text] [Related]
11. Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by
Smith MR; Hong F; Li H; Gordon LI; Gascoyne RD; Paietta EM; Advani RH; Forero-Torres A; Horning SJ; Kahl BS
Leukemia; 2017 Feb; 31(2):517-519. PubMed ID: 27780968
[No Abstract] [Full Text] [Related]
12. Primary colonic lymphoma: report of two cases and a literature review.
Chen L; Sun Q; Chen E; Jin D; Song Z
J Int Med Res; 2021 Jun; 49(6):3000605211017037. PubMed ID: 34082600
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
[TBL] [Abstract][Full Text] [Related]
14. Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.
Ustaalioglu BB; Bilici A; Seker M; Canpolat N; Ozdemir N; Salepci T; Gumus M
Leuk Res; 2010 Apr; 34(4):e108-10. PubMed ID: 19931906
[No Abstract] [Full Text] [Related]
15. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
16. R-CHOP for mantle cell lymphoma.
Klumpp TR
J Clin Oncol; 2005 Sep; 23(27):6802; author reply 6802-3. PubMed ID: 16170194
[No Abstract] [Full Text] [Related]
17. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
18. [Primary non-Hodgkin lymphoma of the liver: case report and review of the literature].
Nasr Ben Ammar C; Chaari N; Kochbati L; Besbes M; Maalej M
Cancer Radiother; 2006 Dec; 10(8):595-601. PubMed ID: 17137818
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak T; Huang H; Jin J; Zhu J; Liu T; Samoilova O; Pylypenko H; Verhoef G; Siritanaratkul N; Osmanov E; Alexeeva J; Pereira J; Drach J; Mayer J; Hong X; Okamoto R; Pei L; Rooney B; van de Velde H; Cavalli F;
N Engl J Med; 2015 Mar; 372(10):944-53. PubMed ID: 25738670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
